Hello and Welcome to Patientsville.com, Your Source for all URSO information. We are dedicated to provide You with URSO safety information. Learn about URSO serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
URSO Safety Reports
Total URSO reports: 54.URSO FDA safety alerts: No.
Reported deaths: 7 Reported hospitalizations: 34.
Take URSO Side Effects Survey or Share Your URSO Story. Read More Here.
Consumer or non-health professional from JAPAN reported URSO problem on Jan 05, 2007. Male patient, 77 years of age, was diagnosed with cholestasis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: condition aggravated, interstitial lung disease, palpitations, pleural effusion. URSO dosage: 300MG PO. During the same period patient was treated with LANSOPRAZOLE, WARFARIN POTASSIUM, FLIVAS. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Dec 29, 2006. Male patient, 56 years of age, was diagnosed with hepatic function abnormal and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin e increased, eosinophil count increased, pleural effusion. URSO dosage: 600MG QD PO. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Dec 28, 2006. Female patient, 68 years of age, was treated with URSO. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. URSO dosage: unknown. Patient died.
URSO problem was reported by a Health Professional from JAPAN on Jan 12, 2007. Male patient, 75 years of age, was diagnosed with liver disorder and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: erythema multiforme. URSO dosage: 300MG PO. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported URSO problem on Jan 15, 2007. Male patient, 56 years of age, was diagnosed with hepatic function abnormal and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin e increased, eosinophil count increased, pleural effusion, pyrexia. URSO dosage: 600MG QD PO. During the same period patient was treated with MERCAZOLE, LASIX, LIVACT, CARVEDILOL. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 44 years of age, was treated with URSO. After drug was administered, patient experienced the following problems/side effects: oral mucosal eruption. URSO dosage: 3000MG, QD; PO. During the same period patient was treated with ALLOPURINOL, LEVOFLOXACIN, MUCODYNE. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Jan 17, 2007. Female patient, 58 years of age, was diagnosed with hepatitis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. URSO dosage: 100MG TID PO. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Male patient, 77 years of age, was diagnosed with jaundice, gastric ulcer and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, palpitations, pleural effusion. URSO dosage: 300MG PO. During the same period patient was treated with LANSOPRAZOLE, WARFARIN POTASSIUM, FLIVAS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Feb 02, 2007. Male patient, 59 years of age, was diagnosed with hepatitis c, prinzmetal angina, gastric ulcer, hyperlipidaemia and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, body temperature increased, condition aggravated, hepatic function abnormal, hepatitis c. URSO dosage: unknown. During the same period patient was treated with NIKORANMART, BUFFERIN, PROMAC, PRAVASTATIN, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2007. Female patient, 58 years of age, was diagnosed with hepatic function abnormal and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal. URSO dosage: 100MG TID PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Jan 25, 2007. Male patient, 56 years of age, was diagnosed with hepatic function abnormal and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin e increased, eosinophil count increased, pleural effusion, pyrexia. URSO dosage: 600MG QD PO. During the same period patient was treated with MERCAZOLET, LASIX, LIVACT, CARVEDILOL. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Feb 22, 2007. Male patient, 80 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: anaemia, melaena. URSO dosage: 200MG TID PO. During the same period patient was treated with NIZATIDINE, LACTULOSE, ALDACTONE, MUCOSOLVAN, TALION, TAURINE, VIT K CAP, DEXTROMETHORPHAN HYDROBROMIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Feb 15, 2007. Male patient, 45 years of age, was diagnosed with hepatic steatosis, hyperuricaemia, hyperlipidaemia, nasopharyngitis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: liver disorder, nasopharyngitis. URSO dosage: 300 MG QD PO. During the same period patient was treated with ALLOPURINOL, LEVOFLOXACIN, MUCODYNE, HUSTAZOL. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2007. Male patient, 45 years of age, was diagnosed with hepatic steatosis, hyperuricaemia, hyperlipidaemia, nasopharyngitis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, nasopharyngitis. URSO dosage: 300MG QD PO. During the same period patient was treated with ALLOPURINOL, LEVOFLOXACIN, MUCODYNE, HUSTAZOL. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Mar 06, 2007. Male patient, 56 years of age, was diagnosed with hepatic function abnormal and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin e increased, eosinophil count increased, pleural effusion, pyrexia. URSO dosage: 600MG QD PO. During the same period patient was treated with MERACAZOLE, LASIX, LIVACT, CARVEDILOL. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Female patient, 40 years of age, was diagnosed with liver disorder and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, jaundice. URSO dosage: 300MG PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Mar 01, 2007. Female patient, 58 years of age, was diagnosed with hepatic function abnormal and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. URSO dosage: 100MG TID PO. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Mar 20, 2007. Female patient, 40 years of age, was diagnosed with liver disorder and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis. URSO dosage: 300MG PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Mar 19, 2007. Female patient, 26 years of age, was diagnosed with hepatic enzyme increased, reflux oesophagitis, convulsion prophylaxis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative, thrombocytopenia. URSO dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, CLONAZEPAM, LASIX, ALDACTONE. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Mar 22, 2007. Male patient, 56 years of age, was diagnosed with hepatic function abnormal and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin e increased, eosinophil count increased, pleural effusion, pyrexia. URSO dosage: 600MG QD PO. During the same period patient was treated with MERCAZOLE, LASIX, LIVACT, CARVEDILOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Mar 27, 2007. Female patient, 26 years of age, was diagnosed with cholelithiasis, hypothyroidism, renal failure, reflux oesophagitis, subdural haemorrhage, constipation and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, hepatic enzyme increased, thrombocytopenia. URSO dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, ALDACTONE, LASIX, LANSOPRAZOLE, CLONAZEPAM, RHUBARB. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2007. Female patient, 40 years of age, was diagnosed with liver disorder and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis. URSO dosage: 300MG. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Apr 10, 2007. Male patient, 80 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: anaemia, melaena. URSO dosage: 200MG TID PO. During the same period patient was treated with NIZATIDINE, LACTULOSE, ALDACTONE, MUCOSOLVAN, TALION, TAURINE, VIT K CAP. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Apr 12, 2007. Male patient was diagnosed with hepatic cirrhosis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, hepatic neoplasm malignant. URSO dosage: 300MG PO. During the same period patient was treated with BAYMYCARD, FAMOTIDINE, LACTULOSE, MUCOSOLVAN L, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Apr 20, 2007. Female patient, 26 years of age, was diagnosed with cholelithiasis, hypothyroidism, renal failure, reflux oesophagitis, subdural haemorrhage, constipation and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, dermatitis exfoliative, erythema, thrombocytopenia. URSO dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, ALDACTONE, LASIX, LANSOPRAZOLE, CLONAZEPAM, RHUBARB. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Apr 20, 2007. Female patient, 58 years of age, was diagnosed with hepatic function abnormal and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal. URSO dosage: 100MG TID PO. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported URSO problem on May 11, 2007. Male patient, 22 years of age, was treated with URSO. After drug was administered, patient experienced the following problems/side effects: delirium. URSO dosage: unknown. During the same period patient was treated with BAKTAR, ALLOPURINOL, MYSLEE, GASTER, PROGRAF. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on May 10, 2007. Female patient was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. URSO dosage: 600 MG. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on May 21, 2007. Female patient, 71 years of age, was diagnosed with hepatic function abnormal, pyrexia, infection, constipation and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, blood pressure decreased, cardio-respiratory arrest, fungal infection, hepatorenal failure, hypoalbuminaemia, hypovolaemia, stevens-johnson syndrome. URSO dosage: 300MG ORAL. During the same period patient was treated with CALONAL, LEVOFLOXACIN, LECICARBON, LASIX, FRANDOL S, GASMOTIN. Patient died.
URSO problem was reported by a Consumer or non-health professional from JAPAN on May 23, 2007. Female patient, 61 years of age, was diagnosed with autoimmune hepatitis, biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: hepatic failure. URSO dosage: 300 MG, ORAL. Patient died.
Consumer or non-health professional from JAPAN reported URSO problem on May 28, 2007. Male patient, 62 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, alkalosis, hypercalcaemia, hypokalaemia, malaise. URSO dosage: 600 MG ORAL. Patient died.
URSO problem was reported by a Consumer or non-health professional from JAPAN on May 31, 2007. Female patient, 60 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. URSO dosage: 600 MG, ORAL. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on June 05, 2007. Female patient, 63 years of age, was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alveolitis allergic, pneumonia. URSO dosage: unknown. Patient recovered.
URSO problem was reported by a Health Professional from JAPAN on June 08, 2007. Male patient, 63 years of age, was diagnosed with hepatic cirrhosis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, no therapeutic response, pyrexia. URSO dosage: 600 MG ORAL. During the same period patient was treated with LIVACT, LANIRAPID. Patient recovered.
Consumer or non-health professional from UNITED STATES reported URSO problem on July 18, 2006. Male patient, child 6 years of age, weighting 46.00 lb, was diagnosed with hepatitis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, pruritus, rash erythematous, red blood cell count decreased, reticulocyte count decreased, white blood cell count decreased. URSO dosage: 250 MG BID. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Health Professional from JAPAN on Nov 16, 2006. Male patient, 59 years of age, was diagnosed with hepatic function abnormal, angina pectoris and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. URSO dosage: unknown. During the same period patient was treated with NIKORANMART, MEVARICH, LANSOPRAZOLE, BUFFERIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Nov 24, 2006. Male patient, 59 years of age, was diagnosed with gastric ulcer, helicobacter infection and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. URSO dosage: unknown. During the same period patient was treated with TAKEPRON, PRAVASTATIN, BUFFERIN, NIKORANMART, CHINESE MEDICINES. Patient was hospitalized and became disabled. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Nov 27, 2006. Male patient, 61 years of age, was treated with URSO. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. URSO dosage: 300 MG PO. During the same period patient was treated with MARZULENE, LEVOTHYROXINE, SELBEX, DEPAS. Patient recovered.
Physician from JAPAN reported URSO problem on July 09, 2007. Male patient, 69 years of age, was diagnosed with liver transplant and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, cholangitis, depressed level of consciousness, hepatic encephalopathy, hepatic failure, hepatitis cholestatic. URSO dosage: unknown. During the same period patient was treated with PREDONINE, BUMINATE. Patient died on 10/16/2006.
URSO problem was reported by a Consumer or non-health professional from JAPAN on June 29, 2007. Female patient, 71 years of age, was diagnosed with hepatic function abnormal, pyrexia, infection, constipation and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardio-respiratory arrest, fungal infection, hypoalbuminaemia, hypovolaemia, jaundice, renal failure, stevens-johnson syndrome. URSO dosage: 300MG, ORAL. During the same period patient was treated with CALONAL, LEVOFLOXACIN, LECICARBON, LASIX, ISOSORBIDE DINITRATE, ALLOPURINOL. Patient died.
Consumer or non-health professional from JAPAN reported URSO problem on July 20, 2007. Male patient, 62 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, alkalosis, hypercalcaemia, hypokalaemia. URSO dosage: 600 MG ORAL. Patient died.
URSO problem was reported by a Consumer or non-health professional from JAPAN on July 20, 2007. Female patient, 59 years of age, was diagnosed with chronic hepatitis, hypertension and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. URSO dosage: 300 MG ORAL. During the same period patient was treated with LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, RAMIAN, OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on July 20, 2007. Male patient, 53 years of age, was diagnosed with hepatitis b, hepatitis chronic active and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: anorexia, hepatic steatosis, interstitial lung disease, pyrexia, seroconversion test positive. URSO dosage: unknown. During the same period patient was treated with ZEFIX. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on July 20, 2007. Female patient, 55 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, postoperative adhesion, postoperative ileus. URSO dosage: 600 MG ORAL. During the same period patient was treated with CHONDRON, TOKISHAKUYAKUSAN, TAURINE, NIFLAN, NEO MEDROL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on July 25, 2007. Male patient, 74 years of age, was treated with URSO. After drug was administered, patient experienced the following problems/side effects: haemorrhagic cerebral infarction. URSO dosage: 300 MG. During the same period patient was treated with NOVO HEPARIN, PLETAL, RADICUT, FAMOTIDINE, VITAMEDIN, MARZULENE, LIVACT. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2007. Male patient, 38 years of age, was diagnosed with hepatitis alcoholic and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, liver disorder. URSO dosage: 300 MG. During the same period patient was treated with NIZATIDINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Aug 06, 2007. Female patient, 66 years of age, was diagnosed with duodenal ulcer and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, hepatic function abnormal. URSO dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, CARVEDILOL, VIT K CAP, ALLOID G, GASCON, VANCOMYCIN. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Male patient, 38 years of age, was diagnosed with hepatic function abnormal, gastritis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, hepatic function abnormal, malaise. URSO dosage: 300 MG ORAL. During the same period patient was treated with ANCINON. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Aug 17, 2007. Male patient, 38 years of age, was diagnosed with hepatic function abnormal, gastritis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, hepatic function abnormal, malaise. URSO dosage: 300 MG ORAL. During the same period patient was treated with NIZATIDINE. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Aug 24, 2007. Female patient, 60 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. URSO dosage: 600 MG ORAL. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Sept 03, 2007. Female patient, 55 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction. URSO dosage: 600 MG ORAL. During the same period patient was treated with CHONDRON, TOKISHAKUYAKUSAN, TAURINE, NIFLAN, NEO MEDROL. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from CANADA on Aug 24, 2007. Male patient, 67 years of age, was diagnosed with cholangitis sclerosing and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, kidney fibrosis, pancreatitis, tubulointerstitial nephritis. URSO dosage: 1000 MG ORAL. During the same period patient was treated with NEXIUM, METFORMIN. Patient recovered.
Consumer or non-health professional from JAPAN reported URSO problem on Sept 06, 2007. Male patient, 38 years of age, was diagnosed with hepatic function abnormal, gastritis and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, condition aggravated, hepatic function abnormal, lymphocyte stimulation test positive. URSO dosage: 300 MG ORAL. During the same period patient was treated with NIZATIDINE. Patient was hospitalized. Patient recovered.
URSO problem was reported by a Consumer or non-health professional from JAPAN on Sept 06, 2007. Female patient, 66 years of age, was diagnosed with duodenal ulcer and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, hepatic function abnormal. URSO dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, CARVEDILOL, VIT K CAP, ALLOID G, GASCON, VANCOMYCIN. Patient was hospitalized. Patient recovered.